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Summary
 
A large, transient population of natural killer (NK) cells appears in the murine uterine mesome-
trial triangle during pregnancy. Depletion of uterine (u) NK cells, recently achieved using
gene-ablated and transgenic mice, results in pathology. Pregnancies from matings of homozy-
gous NK and T cell–deficient tg
 
e
 
26 mice have 
 
,
 
1% of normal uNK cell frequency, no devel-
opment of an implantation site–associated metrial gland, and an edematous decidua with vascu-
lar pathology that includes abnormally high vessel walls/lumens ratios. Fetal loss of 64% occurs
midgestation and placentae are small. None of these features are seen in pregnant T cell–defi-
cient mice. To confirm the role of the NK cell deficiency in these reproductive deficits, trans-
plantation of tg
 
e
 
26 females was undertaken using bone marrow from B and T cell–deficient
 
scid
 
/
 
scid
 
 donors. Engrafted pregnant females have restoration of the uNK cell population, in-
duced metrial gland differentiation, reduced anomalies in the decidua and decidual blood ves-
sels, increased placental sizes, and restoration of fetal viability at all gestational days studied (days
10, 12, and 14). Thus, uNK cells appear to have critical functions in pregnancy that promote
decidual health, the appropriate vascularization of implantation sites, and placental size.
 
L
 
arge, heavily granulated lymphocytes (LGLs)
 
1
 
 are found
in the pregnant uteri of many species, including mice,
rats, pigs, and humans (1). Due to their dependency on es-
trogen and progesterone and their absence from the uteri of
virgin and postpartum animals, these lymphocytes are ex-
pected, but have not yet been proven, to have important,
pregnancy-associated functions. By midgestation in rodents
(days 10–14 of gestation in mice), up to 35% of the cells in
a specialized, pregnancy-induced region within the uterine
musculature called the metrial gland are granulated cells
commonly called granulated metrial gland cells (2). In preg-
nant women, uterine LGLs are more widely dispersed
throughout decidual tissue and represent 70% of the leuko-
cytes in decidual cell suspensions (3).
Immunophenotyping of the surface and the cytoplasmic
granules of rodent and human pregnancy-associated LGLs
has led to the hypothesis that uterine LGLs are lymphocytes
of the NK cell lineage (4, 5). Studies using immune-defi-
cient mice support this conclusion, since LGLs typical in
morphology, location, and frequency have been reported
in T cell–deficient mice (6, 7), T and B cell–deficient mice
(7), and NK1
 
1
 
 T cell–deficient mice (8). However, LGLs
and a metrial gland structure were absent from the uteri of
pregnant IL-2R
 
g
 
 null, p56
 
lck
 
 null 
 
3
 
 IL-2R
 
b
 
 null, and
tg
 
e
 
26 mice (8, 9). Because an NK cell deficiency accompa-
nies the T cell deficiency in the three latter strains, uterine
LGLs are now regarded as members of the NK cell lineage
and designated uterine (u)NK cells (8, 9).
Depletion of uNK cells during pregnancy has only been
achieved genetically. A transgenic strain, tg
 
e
 
26, carrying
high copy numbers (30–35) of the full human (hu) 
 
CD3
 
e
 
gene exhibits NK and T cell deficiencies from fetal life (10,
11). In addition to their splenic NK cell deficiency (10),
uNK cells are deficient in pregnant tg
 
e
 
26 (range from 0 to
3% of the frequency found in immune-competent, random-
bred H-2
 
b
 
 CD1 mice and inbred H-2
 
k
 
 CBA/J mice [8]).
Metrial glands also fail to differentiate in tg
 
e
 
26 implantation
sites (8).
In immune-competent mice, the metrial gland is associ-
ated with the maternal portion of the placenta that consists
of transformed stromal cells known as the decidua. The fe-
tal portion of the placenta has three layers: giant cell tro-
phoblast, spongiotrophoblast, and labyrinthine trophoblast.
Implantation sites in tg
 
e
 
26 mice appear normal, both
grossly and histologically, until day 9 of gestation (counting
from the copulation plug as day 0). By day 10 of gestation,
 
1
 
Abbreviations used in this paper
 
: hu, human; LGL, large granular lympho-
cytes; NO, nitric oxide; NOS, NO synthase; u, uterine.
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the decidua lacks normal cellularity and the large ablumenal
decidual blood vessels have thickened walls. There are pro-
gressive degenerative changes to both the media and en-
dothelium over the next four d of gestation. Vascular
anomalies are not found in other organs of pregnant or
nonpregnant tg
 
e
 
26 mice (8).
Death of 
 
.
 
50% of the tg
 
e
 
26 fetuses occurs in each litter
between days 10 and 14 of gestation, a time correlating
with the decidual pathologies. Surviving tg
 
e
 
26 fetuses have
very small placentae (
 
z
 
50% of normal) and from birth to
adulthood tg
 
e
 
26 mice are smaller than immune-compe-
tent, age-matched controls (36% smaller at 24 h after birth
and 27% smaller at 7 wk of age) (8). These data suggested
that uNK cells have major functional roles in optimizing
pregnancy success.
To understand the role of uNK cells in the reproductive
deficits of tg
 
e
 
26 females, three further studies were under-
taken. First, ectoplacental cones from tg
 
e
 
26 mice were ex-
amined for expression of the 
 
huCD3
 
e
 
 transgene. No ex-
pression was detected. Second, morphometry was applied
to the maternal decidual arterial sinuses, which are murine
equivalents to human spiral arteries (12). Elevated wall to
lumen ratios were found, suggestive of hypertension. Third,
bone marrow was transplanted from 
 
scid
 
/
 
scid
 
 mice into tg
 
e
 
26
females. These donor cells are known to establish periph-
eral NK cells but do not generate mature T cells (13). The
uNK cell lineage was established and the quantified repro-
ductive deficiencies of tg
 
e
 
26 mice were reversed or signifi-
cantly reduced in engrafted, pregnant tg
 
e
 
26 mice.
 
Materials and Methods
 
Mice.
 
8-wk-old random-bred CD1 (H-2
 
b
 
) mice (Charles
River Laboratories, St. Constant, Québec, Canada), inbred CBA/J
mice (H-2
 
k
 
; The Jackson Laboratory, Bar Harbor, ME), C.B-17
 
scid
 
/
 
scid
 
 (SCID) mice (bred at Guelph) and transgenic tg
 
e
 
26 (H-2
 
k
 
bred at Guelph) were used for experiments. Time-matched preg-
nant uteri from syngeneically mated CD1 and CBA/J mice were
used as controls for syngeneically mated tg
 
e
 
26 females counting
the copulation plug as day 0. After euthanasia (CO
 
2
 
 
 
1
 
 cervical
dislocation), pregnant uteri were examined and dissected. Fetal
viability was grossly scored by implant size and color, and then
the implantation sites were processed for histology.
 
Bone Marrow Transplantation.
 
Bone marrow transplantation was
performed in four experiments, as previously described (13, 14).
In brief, female recipients (8-wk-old tg
 
e
 
26 mice; 5/experiment)
were infused with pooled intravenous bone marrow cells, un-
treated or treated with two rounds of anti–Thy-1 antibody (Ab) di-
luted 1:20 in 10 mM PBS 
 
1
 
 guinea pig complement diluted 1:3 in
10 mM PBS (Cedarlane Labs., Hornby, Ontario, Canada) from
male or female C.B-17 SCID mice. Each tg
 
e
 
26 mouse was pre-
conditioned by a single intraperitoneal injection of 5-fluorouracil
(5-FU, 150 mg/kg; Hoffmann-La Roche Ltd., Mississauga, On-
tario, Canada) 48 h before grafting of four donor animal long
bone cell equivalents (ranging from 2.5 
 
3
 
 10
 
6
 
 to 1.75 
 
3
 
 10
 
7
 
 bone
marrow cells). After 3 wk of recovery, the females were paired
with tg
 
e
 
26 males for pregnancies at days 10, 12, or 14 of gesta-
tion. A similar protocol has been shown to establish splenic NK
cells in tg
 
e
 
26 mice (13).
 
Histology.
 
Uteri were fixed in Bouin’s fixative (Fisher Scien-
tific, Whitby, Ontario, Canada) and processed into paraffin. All
implantation sites were serially sectioned transversely at 6 
 
m
 
m and
stained using standard protocols for hematoxylin and eosin, peri-
odic acid–Schiff (PAS) reaction, and Masson’s trichrome connec-
tive tissue stain. The PAS reaction stains the granules of uNK cells a
bright magenta and makes it possible to distinguish them from
other lymphocytes. Masson’s trichrome was used for assessment
of decidual blood vessels. All serial sections were examined.
 
Image Analysis.
 
Micrometer-based uNK cell enumeration has
been previously described (9). All other histological measure-
ments used Northern Exposure System 2.6a (Imagexperts Inc.,
Hollywood, CA) running in Microsoft Windows 3.1 (Microsoft
Corp., Redmond, WA). Eight median independent tissue sec-
tions were analyzed, including the central section and sections on
both sides that were at least 36 
 
m
 
m apart. Cross-sectional area
measurements of decidual blood vessel wall and vessel lumen and
placental cross-sectional areas were measured from a minimum of
two implantation sites per pregnancy. The limits used for the def-
inition of placental cross-sectional area were trophoblast popula-
tions up to and including the trophoblast giant cell layer. The de-
cidua and metrial gland were excluded.
 
Statistical Analysis.
 
Means, standard errors, standard devia-
tions, 
 
P
 
 values, and paired 
 
t
 
 tests were performed using the com-
puter software program Microsoft Excel 5.0 for Windows (Mi-
crosoft Corp.).
 
Results and Discussion
 
Tg
 
e
 
26 Trophoblast Does Not Express the huCD3
 
e
 
 Trans-
gene.
 
One possible explanation for small placentae in
tg
 
e
 
26 pregnancy is aberrant expression of the 
 
huCD3
 
e
 
transgene in trophoblast cells. We first established that nei-
ther CD1 nor tg
 
e
 
26 trophoblast expressed immunoreactive
murine CD3 (data not shown). Then, day 7 tg
 
e
 
26 ectopla-
cental cone tissue (the fetally derived structure from which
all trophoblast arises) was examined for 
 
huCD3
 
e
 
 expression
by Northern blotting and a more sensitive reverse tran-
scriptase PCR approach. Day 7 was selected because it is
the latest developmental time point at which pure tropho-
blast can be isolated. The positive control was RNA from
thymocytes of heterozygous tg
 
e
 
600 mice (13), which carry
a different copy number of the same transgene. Human
CD3
 
e
 
 mRNA was not detected by either method in the
trophoblast tissue but was present in the heterozygote thy-
mocyte RNA (data not shown). Thus, it is unlikely that
the reduced size of placental trophoblast in tg
 
e
 
26 is due to
transgene expression within the trophoblastic lineages.
 
Tg
 
e
 
26 Decidua and Quantification of Decidual Vessel Histo-
pathology.
 
The mesometrial decidua in tg
 
e
 
26 is very un-
usual, being relatively acellular and containing vessels with
thickened walls. Masson’s trichrome staining did not detect
matrix deposition in the cell-deficient regions (data not
shown). Since neutral red staining of cryostat sections has
also eliminated fat deposition as an explanation for this rel-
ative acellularity, we interpret the decidual region as edem-
atous (9).
Normal pregnancy is associated with progressive dilation
of uterine blood vessels and their derivative branches. Since
this was apparently not occurring in tg
 
e
 
26 pregnancies, the
anomalous vessels were studied morphometrically. Table 1 
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summarizes the ratios of tg
 
e
 
26 vessel wall to lumen cross-
sectional area measurements and compares them to mea-
surements of the similar vessels in the ablumenal decidua of
CBA/J. In immune-competent control animals, a progres-
sive increase in the ratio of the lumen to wall was found.
This is consistent with the hypotensive environment pro-
moted in mammalian uterus during mid-gestation (15–17).
At days 10, 12, and 14 of gestation, tg
 
e
 
26 vessel walls
showed a thickened media. This was measured at 2.7, 2.0,
and 4.7 times greater than the media thickness in control,
gestational day–matched CBA/J. The decidual vessels in tg
 
e
 
26
had relatively less lumen, suggesting vasoconstriction or fail-
ure to undergo arterial vessel modification that would facil-
itate vasodilation. Either mechanism would be expected to
promote thickened decidual vessel walls and a more hyper-
tensive environment in the tg
 
e
 
26 uterus at midpregnancy.
Masson’s trichrome intensely stained the muscular compo-
nent of the vessel walls (red). There was little evidence of
increased connective tissue reactivity (blue) on days 10, 12,
and 14 of gestation. This demonstrates that the media was
the thickened component in tg
 
e
 
26 decidual vessel walls.
 
NK Cell Reconstitution in tg
 
e
 
26 Females Infused with SCID
Bone Marrow.
 
Six features of pregnancies in tg
 
e
 
26 females
have been identified as different from pregnancies in im-
 
Table 1.
 
Summary of Ratios of Mean Decidual Vessel Wall to Lumen Cross-sectional Area Measured at Days 10, 12, and 14 of Gestation in 
tg
 
e
 
26 and CBA/J Mice
 
Mouse
strain
Day 10 of gestation
(mean W/L
 
*
 
 
 
6
 
 SEM)
Day 12 of gestation
(mean W/L 
 
6
 
 SEM)
Day 14 of gestation
(mean W/L 
 
6
 
 SEM)
tg
 
e
 
26 2.77 
 
6
 
 0.55
 
‡
 
1.32 
 
6
 
 0.51
 
§ 2.48 6 0.56‡
CBA/J 1.03 6 0.17 0.67 6 0.42 0.53 6 0.10
*W/L 5 vessel wall cross-sectional area/lumen cross-sectional area ratio measured at 3200.
‡P ,0.01 as compared to CBA/J.
§P ,0.1 as compared to CBA/J.
Table 2. Data Summary for SCID Bone Marrow–inoculated tge26 Females at Days 10, 12, and 14 of Gestation
Day of
gestation
No. of
mice Thy-1 tx*
No. of uNK cells‡
(mean 6 SEM)
No. of viable/
total No.
of implants
Percent
viability
in utero
NK reconstituted§
10 1 no 54.2 6 10.9i 8/9 88.8
12 1 yes 90.6 6 14.2i 5/6 83.3
14 2 no 108.9 6 20.3i 13/14 92.9
14 3 yes 124.3 6 26.3i 24/27 88.8
NK nonreconstituted§
10 1 no 4.1 6 1.9i 3/4 75.0
12 1 yes 5.0 6 5.8i 7/10 70.0
14 1 no 1.45 6 1.2i 8/9 88.8
tge26
10 6 no 1.3 6 1.2i 47/59 79.7
12 4 no 0.2 6 0.3i 25/41 61.0
14 4 no 1.7 6 1.2i 9/25 36.0
CD1/CBA/J
10 11 no 134.8 6 12.4 110/121 90.9
12 30 no 161.4 6 16.8 358/371 96.5
14 13 no 229.2 6 12.2 127/138 92.0
*Some SCID bone marrow was pretreated with a-Thy-1 Ab before inoculation of tge26 females.
‡The frequency of uNK cells, as detected by periodic acid-Schiff–reactive granules was counted using a 10 mm2 grid, at 3250 for all implantation
sites, using 10 median sections per implantation site, a minimum of 2 implantation sites per pregnancy.
§As assessed by splenic effector lytic cell assay against 51Cr-labeled YAC-1 targets.
iP ,0.01 as compared to gestational day–matched pooled CBA/J 1 CD1 values.220 Uterine Natural Killer Cell Reconstitution during Pregnancy
mune-competent or in T cell–deficient mice. These fea-
tures are as follows: loss of uNK cells to ,1% of normal;
absence of metrial gland development; acellularity and
edema in the decidua; increased wall/lumen ratios in the
major ablumenal mesometrial vessels of the decidua; small
placental size; and midgestational fetal death (8). To deter-
mine whether NK cell deficiency makes a major contribu-
tion to any or all of these reproductive deficits, females
were grafted with SCID (NK1 T2 B2) bone marrow,
which cannot establish the T cell lineage. Half of the recip-
ients received bone marrow that had been pretreated with
a-Thy-1 Ab 1 complement before injection while the
other half received untreated bone marrow. Of the 20 re-
cipients, only 10 mated successfully and these were from
both of the marrow pretreatment protocols (Table 2). Of
these 10, 7 were considered to have splenic NK cell recon-
stituted as assessed by standard chromium release assays
(mean percentage of specific lysis of 36.2% 6 2.1 at E:T 5
100:1 compared to mean percentage of specific lysis of
42.0%  6 5.0 for CD1 at the same E:T ratio). Three females
who had relatively nonlytic spleen cells (mean percentage
of specific lysis of 9.1% 6 2.0 at E:T 5 100:1 compared to
mean percentage of specific lysis of 4.8% 6 3.7 for unma-
nipulated tge26 at the same E:T) were considered to be
non-reconstituted, and were analyzed separately from the
first seven females.
Uterine Changes in Pregnant Reconstituted tge26. uNK cells
were present in considerable numbers in the seven NK cell
reconstituted females but not in the remaining three fe-
males. Implantation sites from two immune-competent
strains of mice (CD1 and CBA/J) were used to establish the
parameters for normal number, size, and granularity of uNK
cells on each of days 10, 12, and 14 of gestation. The fre-
quency of uNK cells was not significantly different be-
tween CD1 and CBA/J strains at any gestational day stud-
ied. Therefore, the values from these two strains were
pooled and are referred to as “control” in Table 2. In non-
manipulated tge26, the number of uNK cells were statisti-
cally ,1% of control at days 10, 12, and 14 of gestation
(reference 8 and Table 2). When compared to control im-
mune-competent females, day 10 NK cell reconstituted
females had 40.2%, day 12 females had 56.1% and day 14
females had 49.8% of normal frequencies of uNK cells (P
,0.01; Table 2 and Fig. 1). Many uNK cells in the recon-
stituted females were associated with the main decidual
blood vessels (Fig. 1). In contrast, low numbers of uNK cells
(1–3.1% of immune-competent females, which is also
equivalent to the number of uNK cells found in untreated
tge26 females) were present in the three bone marrow in-
fused, nonreconstituted tge26 females (Table 2).
Histologically, the placentae from the NK cell reconsti-
tuted females appeared larger than those in tge26 females
and the implantation sites resembled those in immune-
competent females, because they included a well developed
metrial gland (Fig. 1). Reference standards for placental
cross-sectional areas were obtained by measurements of
CD1 and CBA/J implantation sites. Since these were not
statistically different from each other at the gestational days
used (10, 12, and 14), the data were pooled to provide a
larger immune competent control data set than that used
for control reference values in our earlier publication (8).
The mean cross-sectional areas of unmanipulated tge26
placentae were 53% of the mean at day 10 (P ,0.01, n 5 6
mice), 50% of the mean at day 12 (P ,0.01, n 5 4 mice)
and 47% of the mean at day 14 (P ,0.01, n 5 4 mice) con-
trol placentae (Fig. 2).
Placental cross-sectional areas for the NK cell–reconsti-
tuted females were significantly larger than cross-sectional
areas measured for time-matched homozygous tge26 fe-
males or for SCID bone marrow–infused females who
failed to show evidence for engraftment (Fig. 2). Placentae
from all NK cell reconstituted tge26 mothers (independent
Figure 1. Comparison of day 12 placental morphology in NK cell–
reconstituted tge26 (A, C, and E) and tge26 (B, D, and F) females. Pla-
cental (p) cross-sectional area measurements of NK cell–reconstituted tge26
mice (NK1; A) were larger by 27–34% than gestational age-matched ho-
mozygous tge26 mice (B). The NK1 females had well-developed metrial
glands (mg) and higher cellularity in the decidua (d), whereas metrial gland
development was absent (mg2) and the decidua was edematous in tge26
females. When compared to control immune-competent females, NK1
females had 40–56% normal frequencies of uNK cells (arrows; C) whereas
tge26 females had 0–3% normal uNK cell frequencies (arrow; D). In the
NK1 group of females, uNK cells (arrows) were frequently found sur-
rounding decidual blood vessels and occasionally found within the vessel
lumens (E). (F) demonstrates the decidual vessel anomalies found in tge26
mice including thickened vessel walls (asterisks); A and B, bar 5 1,000
mm; C and D, bar 5 40 mm, E and F, bar 5 100 mm; (A, B, and F)
stained with hematoxylin and eosin; (C–E) stained with periodic acid–
Schiff.221 Guimond et al.
of the marrow graft preparation protocol) were 28% (day
10), 27% (day 12), and 34% (day 14) larger than placentae
from homozygous tge26 mice (P ,0.01) but were 26%
(day 10), 32% (day 12), and 29% (day 14) smaller than pla-
centae from the immune-competent control mice (P
,0.01). Days 10, 12, and 14 placental cross-sectional areas
from bone marrow–infused, nonreconstituted mice were
not statistically different than those from homozygous tge26
placentae (Fig. 2). Since normal levels of uNK cells were not
established in the engrafted mice, it is unclear whether or not
the placental sizes achieved represent the maximum placental
growth effects that can be promoted by uNK cells.
The vascular anomalies found in unmanipulated preg-
nant tge26 mice may or may not underlie the limited pla-
cental growth seen in these pregnancies. In the NK cell–
reconstituted tge26 females, no major anomalies of the
decidua or placental vasculature were found (Fig. 1). The
lumen size in decidual vessels of the NK cell–reconstituted
females was larger than that in nonreconstituted tge26 mice
and appeared to increase with gestational length. The wall/
lumen ratios were similar to those in the immune-compe-
tent controls (Tables 1 and 3), suggesting that engraftment
had restored normal dilation of the decidual arterioles. This
occurred in spite of the observation that uNK cell numbers
were lower than in immune-competent mice. Minor varia-
tions from the immune-competent controls were found in
implantation sites from only two of the seven NK cell–
reconstituted females, the two females with the lowest uNK
cell numbers (38.7 and 42.9% of immune-competent con-
trols, respectively), and this suggests a redundancy in the
uNK cell numbers regarding this trait. In these two females,
the decidual region appeared fluid filled, the width of the
myometrial smooth muscle was increased on the mesome-
trial side with uNK cells scattered within these smooth
muscle fibers, and a small developing metrial gland was
present. The trophoblast giant cell layer appeared mildly dis-
organized, having produced isolated islands of trophoblast
giant cells, and trophoblast giant cells were found in appo-
sition to decidual vessels. This is the location that many
uNK cells occupy in mice. Blood vessels and placentae
from bone marrow–infused but NK cell–nonreconstituted
tge26 females resembled those from homozygously mated,
nonmanipulated tge26 females (Tables 1 and 3).
Viability of the fetuses from the NK cell–reconstituted
tge26 females was equivalent to fetal viability in immune-
competent mice at all gestational days studied (Table 2).
Viability of the fetuses from the single time-matched preg-
nancies available in bone marrow–infused, nonreconsti-
tuted females was below control levels at days 10 and 12 of
gestation but, unexpectedly, equivalent to control in the
one day 14 female, for which we have no explanation.
Thus, reestablishment of 40–56% of uNK cells restored va-
sodilation in decidual arteries, promoted placental size, and
promoted fetal viability.
One interpretation of the tge26 experiments is that uNK
cells downregulate vascular smooth muscle cell (VSMC)
numbers during pregnancy or promote VSMC relaxation.
IFN-g inhibits proliferation of rat VSMC through the in-
duction of nitric oxide synthase (NOS) activity which in
Figure 2. Placental cross-sectional area measurements of tge26 recipi-
ents of SCID bone marrow, homozygous tge26 and control mice. Pla-
cental cross-sectional area measurements of NK cell–reconstituted tge26
mice (NK1) were larger by 28% at day 10, 27% at day 12, and 34% at day
14 of gestation as compared to gestational age-matched homozygous
tge26 mice (*P ,0.01). Day 10, day 12, and day 14 placental cross-sec-
tional area measurements from bone marrow–infused, nonreconstituted
mice (NK2) were not statistically different than homozygous tge26 pla-
centae. Day 10 and day 12 placentae were measured at 3160 magnifica-
tion, whereas day 14 placentae were measured at 3140 magnification.
Table 3. Summary of Ratios of Mean Decidual Vessel Wall to Lumen Cross-sectional Area Measured at Days 10, 12, and 14 of Gestation
Mouse
strain
Day 10 of gestation
(mean W/L* 6 SEM)
Day 12 of gestation
(mean W/L 6 SEM)
Day 14 of gestation
(mean W/L 6 SEM)
NK1‡ 1.27 6 0.32§ 0.44 6 0.27§ 0.68 6 0.12§
NK2‡ 2.51 6 0.41i 1.21 6 0.39¶ 2.13 6 0.37i
*W/L 5 vessel wall cross-sectional area/lumen cross-sectional area ratio measured at 3200 magnification.
‡NK2 5 three NK cell nonreconstituted tge26 females; NK1 5 seven NK cell reconstituted tge26 females.
§Not statistically different than CBA/J.
iP ,0.01 as compared to CBA/J.
¶P ,0.1 as compared to CBA/J.222 Uterine Natural Killer Cell Reconstitution during Pregnancy
turn generates NO (18). NO is a major vasodilator that acts
on vascular smooth muscle in many sites, including the
uterus (19, 20). Infusion of an inhibitor of NOSs during
pregnancy in rats caused hypertension and fetal growth re-
tardation, suggesting that a reduction in the synthesis of
NO may contribute to the pathogenesis of pregnancy-
induced hypertension (21). IFN-g and iNOS are both
products of mouse uNK cells (7, 22), as is TNF-a (23), an-
other hypotensive molecule (24, 25). A number of histolo-
gists have noted a strong association of rodent uNK cells
with blood vessels, and this association was reestablished in
bone marrow–reconstituted tge26 females (Fig. 1 F). It has
been previously suggested that uNK cells are involved in
blood pressure regulation because hypertensive rats in
which an artificial deciduomata had been induced experi-
enced a fall of blood pressure at the time uNK cells ap-
peared and an elevation of blood pressure when uNK cells
disappeared despite persistence of the deciduomata (26).
However, preliminary experiments involving serial blood
pressure recordings by tail cuff in four conscious pregnant
tge26 females failed to demonstrate statistically significant
systemic hypertension over the first 16 d of gestation in
comparison to four nonpregnant tge26 females (Luross,
J.A., and B.A. Croy, unpublished data).
Three explanations have been considered for incomplete
uNK cell reconstitution in tge26 females. First, the number
of bone marrow cells or the proportion NK cell progeni-
tors within the bone marrow suspension used for treatment
in this study may not have been sufficient for full reconsti-
tution of the uNK cell population. Since bone marrow was
pooled from four donors for each recipient, this is not a
strong argument. Second, the 3-wk time interval between
the time of bone marrow treatment and the time of mating,
in addition to the 10–14 d of pregnancy may have been too
long, and thus bypassed the optimal interval (3 wk) when
splenic NK cell numbers peak in tge26 mice reconstituted
with recombination activating gene 2 (RAG-2) null bone
marrow (13). Third, the 5-FU pretreatment may not have
displaced the recipient marrow cells sufficiently to provide
an adequate niche for optimal donor marrow engraftment.
The decidual blood vessel structure and placental mor-
phology were improved or fully restored in the seven re-
constituted tge26 mice despite their lower than normal
frequency of uNK cells. Therefore, the placental size incre-
ments achieved in the NK cell–reconstituted tge26 versus
nonmanipulated tge26 may represent the maximal growth
promotion by uNK cells with other mechanisms, account-
ing for the deficit in size between reconstituted tge26 and
immune-competent controls. One further requirement to
promote full placental growth may be immune-compe-
tence in the fetal compartment. We have reported else-
where that embryo transfers demonstrate that unilateral
fetal or maternal NK cell deficiency can reduce placental
size (8).
These in vivo studies have better defined the functional
role of the immune system and the role of uNK cells in the
pregnant uterus in particular. They exclude T cells and
NK1 T cells as essential participants in pregnancy success,
supporting earlier studies of nu/nu and IL-2 null 3 b2m
null mice (6–8). These studies identify the NK cell lineage
as important for normal development of implantation sites
and highlight the mesometrial decidua and vasculature as
important sites for uNK cell function. These studies do not
support the previously postulated function of uNK cells to
limiting trophoblast cell growth and invasion. On the con-
trary, they show that maternal uNK cells promote placental
growth and thereby the growth of the developing fetus. It
remains unclear whether promotion of trophoblast growth
is a direct or indirect effect.
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